Needle-exchange bill passes California senate by one vote. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Needle-exchange bill passes California senate by one vote. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

AIDS Policy Law. 1997 Jun 27;12(12):4. Unique Identifier : AIDSLINE MED/97702697

Abstract: California's Senate approved legislation authorizing experimental needle-exchange programs in four cities: San Francisco, Los Angeles, San Jose, and Long Beach. Officials in these cities will decide whether their city will participate. The proposed legislation cited several studies showing that HIV transmission rates declined in cities that have such programs. The project is seen as critical because changing patterns of injection-drug use indicate that cocaine is replacing heroin as the injection-drug user's drug of choice. Cocaine users inject more frequently than heroin users, increasing the risk of HIV infection.

Keywords: *HIV Infections/PREVENTION & CONTROL *Needle-Exchange Programs/LEGISLATION & JURISPRUD
971030
M97A1288

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .